EXACERBATIONS OF THE USE OF SELENIUM-CONTAINING DRUGS IN PREGNANT WOMEN IN THE PREVENTION OF FETOPLACENTAR DEFICIENCY. Web med. 2025;3(2):261-264. Accessed April 16, 2026. https://webofjournals.com/index.php/5/article/view/3279